The findings could potentially lead to new therapies and could stop the growth of cancers

Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications

The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK 

The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK

Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide

The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda